Stash House CO Products Recalled in Colorado After Pesticide Testing Exceeds Limits

31 December 2025

Colorado regulators issued a statewide health and safety advisory and voluntary recall for certain marijuana products made by CC Brands, LLC, which operates as Stash House CO. The action followed additional testing that found pesticide levels above state limits.

The advisory was released on December 31, 2025. It came from the Colorado Department of Revenue, working with the Colorado Department of Public Health and Environment.

The recall covers marijuana concentrates used in vaporizer cartridges and infused pre-rolled products. These items were sold in both the medical and retail cannabis markets across Colorado.

Regulators said the products may pose a public health risk. The concern centers on pesticide levels that exceeded limits set under Colorado Marijuana Rule 4-215. Officials view inhaled products as a higher concern because contaminants can enter the lungs directly.

According to the advisory, one production batch initially passed required testing. Later retesting showed pesticide levels above the allowed threshold. That batch is identified as 1312 and tested above limits for chlorfenapyr.

The advisory also lists several other batches as potentially affected. These include batches 1340, 1341, 1342, 1343, 1348, 1352, 1355, and 1375. Regulators said these batches used marijuana concentrate that failed testing for a different pesticide - fluopyram. They were included in the recall as a precaution.

CC Brands worked with the Marijuana Enforcement Division to carry out the voluntary recall. The affected products were made under Regulated Marijuana Products Manufacturer Licenses 404R-00047 and 404-00302.

State officials said the products were sold between February 27, 2025, and December 11, 2025. Distribution reached 295 licensed marijuana dispensaries statewide. These included locations in Denver, Colorado Springs, Aurora, Boulder, Fort Collins, Pueblo, and smaller communities.

Consumers who think they purchased recalled items are advised to check product labels. The manufacturer license number and production batch number can help confirm whether a product is affected.

Regulators advised consumers to destroy recalled products or return them to the store where they were purchased. Stores are expected to handle proper disposal. Health officials also said anyone who experiences side effects after use should seek medical care and report the issue to the Marijuana Enforcement Division through its reporting system.

As of the advisory’s release, state officials said they had not confirmed any illnesses linked to the products. They also did not disclose how many units were sold. The recall remains active while regulators monitor compliance and verify that affected products are removed from shelves.

For patients who rely on cannabis for medical reasons, Colorado maintains an active medical marijuana program. Individuals who meet state qualifying conditions may be able to access regulated cannabis products through a licensed medical provider, which may offer additional oversight and product controls.